Cat.#: ACPP-1638
| Despition | CNTF Human Recombinant |
| SIZE | 5 µg |
| Sequence | Met-Ala-Phe-Thr-Glu. |
| Purity | > 98.0% (SDS-PAGE) |
| Form | Sterile Filtered White lyophilized (freeze-dried) powder. |
| Storage | Lyophilized was stored and desiccated below -18°C. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1500 | Mouse PEBP1 Protein (AC1500) | 5 µg | inquiry |
| ACPP-1631 | Human IMPDH1 Protein (AC1631) | 2 µg | inquiry |
| ACPP-1769 | Human VAT1 Protein (AC1769) | 2 µg | inquiry |
| ACPP-1826 | Human CRYGN Protein (AC1826) | 5 µg | inquiry |
| ACPP-1402 | Mouse CDNF Protein (AC1402) | 5 µg | inquiry |
| ACPP-1365 | Progesterone Receptor Blocking Peptide (AC1365) | 250 µg | inquiry |
| ACPP-1189 | PDE6C Blocking Peptide (AC1189) | 250 µg | inquiry |
| ACPP-1453 | Human ACOT7 Protein (AC1453) | 5 µg | inquiry |
| ACPP-1413 | Human STX3 Protein (AC1413) | 5 µg | inquiry |
| ACPP-1846 | Human FGF 9 Protein (AC1846) | 5 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.